Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
6.89
18.17
263.72%
Share Warrants & Outstandings
Total Reserve
300.97
379.93
-78.96
-20.78%
Shareholder's Funds
326.02
386.83
-60.81
-15.72%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
5.11
-5.11
-100.00%
Secured Loans
0.00
5.11
-5.11
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-2.08
-0.82
-1.26
-153.66%
Other Long Term Liabilities
0.06
2.81
-2.75
-97.86%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
2.66
-0.63
-23.68%
Total Non-Current Liabilities
0.01
6.92
-6.91
-99.86%
Current Liabilities
Trade Payables
156.84
62.76
94.08
149.90%
Other Current Liabilities
11.00
29.12
-18.12
-62.23%
Short Term Borrowings
10.50
62.48
-51.98
-83.19%
Short Term Provisions
0.17
0.26
-0.09
-34.62%
Total Current Liabilities
178.51
154.62
23.89
15.45%
Total Liabilities
504.55
548.37
-43.82
-7.99%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
85.07
25.99
30.55%
Less: Accumulated Depreciation
61.36
39.71
21.65
54.52%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
45.37
4.33
9.54%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
5.00
-4.73
-94.60%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
168.61
-116.66
-69.19%
Long Term Loans & Advances
2.64
63.62
-60.98
-95.85%
Other Non Current Assets
15.30
0.00
15.30
0.00%
Total Non-Current Assets
128.38
282.60
-154.22
-54.57%
Current Assets Loans & Advances
Current Investments
53.86
0.00
53.86
0.00%
Inventories
74.48
46.85
27.63
58.98%
Sundry Debtors
215.87
164.72
51.15
31.05%
Cash and Bank
19.74
27.78
-8.04
-28.94%
Other Current Assets
11.48
2.72
8.76
322.06%
Short Term Loans and Advances
0.75
23.70
-22.95
-96.84%
Total Current Assets
376.17
265.78
110.39
41.53%
Net Current Assets (Including Current Investments)
197.66
111.15
86.51
77.83%
Total Current Assets Excluding Current Investments
322.31
265.78
56.53
21.27%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
548.37
-43.82
-7.99%
Contingent Liabilities
25.26
50.91
-25.65
-50.38%
Total Debt
10.50
61.91
-51.41
-83.04%
Book Value per share (adjusted)
32.53
561.27
-528.74
-94.20%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024






